Global HPC, Data Analysis, Storage & Management in Life Sciences Market to Reach US$120.1 Billion by 2030
The global market for HPC, Data Analysis, Storage & Management in Life Sciences estimated at US$54.8 Billion in the year 2024, is expected to reach US$120.1 Billion by 2030, growing at a CAGR of 14.0% over the analysis period 2024-2030. Data Analysis Software & Workbenches, one of the segments analyzed in the report, is expected to record a 11.8% CAGR and reach US$44.8 Billion by the end of the analysis period. Growth in the Data Analysis Services segment is estimated at 14.4% CAGR over the analysis period.
The U.S. Market is Estimated at US$15.1 Billion While China is Forecast to Grow at 13.4% CAGR
The HPC, Data Analysis, Storage & Management in Life Sciences market in the U.S. is estimated at US$15.1 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$18.6 Billion by the year 2030 trailing a CAGR of 13.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.8% and 11.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.1% CAGR.
Global HPC, Data Analysis, Storage & Management in Life Sciences Market - Key Trends and Drivers Summarized
Why Is HPC, Data Analysis, Storage & Management Crucial in Life Sciences?
High-performance computing (HPC), data analysis, storage, and management are crucial components of the life sciences industry, enabling researchers to process and analyze massive datasets generated by genomics, proteomics, and drug discovery. HPC allows life sciences companies to run complex simulations, model biological processes, and analyze vast amounts of data in real time, accelerating research and development. Data management is equally important, as it ensures that the enormous volumes of data produced in life sciences are stored securely and can be accessed and shared efficiently. With the growing complexity of life sciences research, particularly in precision medicine, the need for advanced data analytics and storage solutions has become more critical than ever.
How Are Technological Advancements Shaping HPC in Life Sciences?
Technological advancements in cloud computing, artificial intelligence (AI), and big data analytics are driving the use of HPC in life sciences. Cloud-based HPC solutions are gaining popularity because they offer scalability, flexibility, and cost-efficiency, allowing researchers to access powerful computing resources without investing in expensive on-premise infrastructure. AI and machine learning are also revolutionizing data analysis in life sciences, enabling more accurate predictions and personalized treatments based on complex biological data. Additionally, innovations in data storage technologies, such as the use of advanced cloud storage solutions and secure data-sharing platforms, have enhanced the ability to manage and process large datasets generated by next-generation sequencing and other advanced research techniques.
How Do Market Segments Define the Growth of HPC, Data Analysis, Storage & Management in Life Sciences?
Components include hardware, software, and services, with services such as cloud-based HPC solutions and data management consulting seeing significant growth. Deployment models include on-premise, cloud, and hybrid systems, with cloud-based HPC rapidly gaining traction due to its scalability and flexibility. Applications include drug discovery, genomics, proteomics, and clinical trials, with drug discovery being the largest segment as HPC accelerates the simulation and testing of new compounds. The market also caters to academic research institutions, pharmaceutical companies, and biotech firms, with pharmaceutical companies leading in the adoption of HPC for precision medicine and personalized healthcare.
What Factors Are Driving the Growth in the HPC, Data Analysis, Storage & Management Market in Life Sciences?
The growth in the HPC, data analysis, storage, and management market in life sciences is driven by several factors, including the increasing complexity of biological data, the growing use of AI in drug discovery, and the rising adoption of cloud-based computing solutions. As the life sciences industry continues to generate enormous volumes of data from genomics, proteomics, and clinical trials, the need for powerful HPC systems to process and analyze this data is growing. AI and machine learning are also playing a critical role in advancing drug discovery and personalized medicine, driving demand for advanced data analytics platforms. Additionally, the shift toward cloud-based solutions, which offer cost-effective scalability and enhanced collaboration, is further fueling the growth of this market. The push for precision medicine and the growing focus on developing treatments for complex diseases are key drivers of demand for HPC and data management in life sciences.
SCOPE OF STUDY:TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.
We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.
As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.
To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!
APRIL 2025: NEGOTIATION PHASE
Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.
JULY 2025 FINAL TARIFF RESET
Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.
Reciprocal and Bilateral Trade & Tariff Impact Analyses:
USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.
Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook